US OptionsDetailed Quotes
SKX241220C62500
- 1.50
- -0.10-6.25%
15min DelayClose Nov 18 16:00 ET
1.74High1.40Low
1.65Open1.60Pre Close134 Volume314 Open Interest62.50Strike Price21.31KTurnover29.23%IV5.32%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier32DDays to Expiry1.50Extrinsic Value100Contract SizeAmericanOptions Type0.4056Delta0.0740Gamma41.91Leverage Ratio-0.0350Theta0.0202Rho17.00Eff Leverage0.0694Vega
Skechers USA Stock Discussion
Sign in to post a comment
$Visionary Holdings (GV.US)$ $Western Digital (WDC.US)$ $Integrated Media Technology (IMTE.US)$ $Deckers Outdoor (DECK.US)$ $MediaCo (MDIA.US)$ $Skechers USA (SKX.US)$ $Regulus Therapeutics (RGLS.US)$ $Abits (ABTS.US)$ $Spark I Acquisition Corporation (SPKL.US)$ $Tapestry (TPR.US)$ $Antelope Enterprise (AEHL.US)$ $Jeffs' Brands (JFBR.US)$ $Lyell Immunopharma (LYEL.US)$ $Smart Powerr (CREG.US)$ $Bionomics (BNOX.US)$
📊⚡️📊
📊⚡️📊
6
4
Since the beginning of this year, $Nike (NKE.US)$ and $Lululemon Athletica (LULU.US)$ have fallen by 32.7% and 43.7%, respectively, significantly underperforming the $Consumer Discretionary Select Sector Index (.SIXY.US)$, which has risen by 5.73%. However, companies such as $On Holding (ONON.US)$, $Deckers Outdoor (DECK.US)$, and $adidas AG (ADDYY.US)$ have performed well in the athletic apparel sector, with increases of 37.3%, 32.9%, ...
+1
53
3
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
Morning Movers
Gapping up
$Lyft Inc (LYFT.US)$ The ride-sharing company's shares increased by over 3% following upgrades from multiple analysts to 'buy' after an impressive investor day. Lyft projected a gross bookings compound annual growth rate of around 15% from 2024 to 2027.
See how Lyft's options are moving today.
$Skechers USA (SKX.US)$ The footwear maker's stock climbed 2% after Bank of America upgraded the stock to 'buy' ...
Gapping up
$Lyft Inc (LYFT.US)$ The ride-sharing company's shares increased by over 3% following upgrades from multiple analysts to 'buy' after an impressive investor day. Lyft projected a gross bookings compound annual growth rate of around 15% from 2024 to 2027.
See how Lyft's options are moving today.
$Skechers USA (SKX.US)$ The footwear maker's stock climbed 2% after Bank of America upgraded the stock to 'buy' ...
29
1
Insider sale of Skechers U.S.A shares at current price of US$60.81 raises caution. Despite insiders owning a significant portion, the selling activity over the past year is concerning.
Skechers' Q4 sales underperformed, causing a 10.8% share drop. COO David Weinberg remains hopeful as retailers' inventory management changes, impacting wholesale sales positively.
Piper Sandler analysts find Boston Scientific, Expedia Group, Progressive Corporation, Skechers U.S.A., Synovus Financial, and Zoetis Inc. stocks attractive due to their individual strengths and positive trends.
Skechers's falling ROCE despite increased capital suggests its multi-bagger potential might not be high. Keep an eye on future earnings to gauge investment contributions.
Insider sales of Skechers U.S.A's stock, particularly by its Co-Founder, could evoke investor worry. Despite scarce insider buying, their high ownership level indicates a vested interest. Still, the recent sales history might cause unease for potential investors.
While a significant amount of insider selling could concern investors, insiders still owning major stakes implies interest alignment with shareholders. However, lack of significant insider buying in the past year triggers less confidence.
Skechers U.S.A.'s stock is undervalued and might drop further due to high beta. But its future outlook hasn't been factored into the price. Thus, it may be a good time to buy or increase SKX holdings given its projected earnings growth and current undervaluation.
No comment yet
Trademark-17 : why some your marking in red ?
Stock_Drift OP Trademark-17 : I’m not marking them, it’s a live ticker. It’s moving to the price fluctuations.
F HALE : where do i find this ticker
Trademark-17 : what your think for CREG for tomorrow?